Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lomecel-B in mild Alzheimer's disease
NCT05233774Phase 2Completed
- Sponsor
- Longeveron
- Start
- Dec 2021
- Primary completion
- Sep 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of laromestrocel in Alzheimer's disease (AD), sponsored by Longeveron. Started Dec 2021; status: completed.
02
Drugs
laromestrocel
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT05233774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05233774.